Takeda Pharma

För 6 år sedan misslyckas ni med liothyroninet och idag är det Elvanse tur. Det orsakades brist på Elvanse i både USA och England och efter det så finns det folk i dessa länder som skriver att medecinen inte fungerar som den ska längre. …

6 years ago you failed with liothyronine and today it's Elvanse's turn. There was a shortage of Elvanse in both the USA and England and after that there are people in these countries who write that the medicine no longer works as it should. Today several discussion forums in Sweden are littered with the same words. Elvanse doesn't work the same way anymore. The company is growing but you don't let your production catch up first, so that there is enough medicine for your customers. It's not hard to calculate what the consequences will be of stressed production. The company should stand for honesty and gain a better reputation but you as a company have gotten in over your head when you try to take over all production worldwide. I hope your CEO in Japan one day realizes that those who gape after a lot often miss the whole point.

Bra CSR arbete, inspirerande.